THE GLOBAL OPHTHALMOSCOPES MARKET SIZE WAS VALUED AT USD 53.02 MILLION IN 2021 AND IS EXPECTED TO REACH USD 73.90 MILLION BY 2027, GROWING AT A CAGR OF 5.69%.

The Global Ophthalmoscopes Market Size, Growth, Share, Trends Analysis Report by:

  • Type: Direct and Indirect
  • Indication: Glaucoma, Diabetic Retinopathy, Age-Related Macular Degeneration, Retinal Detachment, and Other
  • End-User: Eye Clinics & Hospitals, Ophthalmologists & Optometrists, and Ambulatory Surgical Centres
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Global Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022-2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

264 Pages

icon-table

105 Tables

icon-chart

129 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

25 Companies

icon-market

4 Market Segment

OPHTHALMOSCOPES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (2027) USD 73.90 Million
MARKET SIZE (2021) USD 53.02 MILLION
CAGR (2022-2027) 5.69%
BASE YEAR 2021
FORECAST YEAR 2022-2027
LARGEST MARKET North America
MARKET SEGMENTS Type, Indication, and End-User
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia

INDUSTRY OVERVIEW

The global ophthalmoscopes market was valued at USD 53.02 million in 2021 and is expected to reach USD 73.90 million by 2027, growing at a CAGR of 5.69%.

Ophthalmoscope (Fundoscopy) is a medical device used to perform ophthalmoscopy to understand the health of vitreous humor, optic disc, & retina of the eye. So, ophthalmoscopy is the most vital part of eye examination and is used to detect the symptoms of retinal vascular diseases such as cataracts, glaucoma, diabetic retinopathy, and age macular degeneration. It involves eye checkups for patients who suffer from diabetes mellitus conditions in which ophthalmoscopy plays a vital role in routinely monitoring the diabetic retinopathy condition.

The rising prevalence of eye diseases is driving the growth of the eye testing equipment market. Around 596 million people are suffering from distance vision impairment globally, of which 43 million people are blind. Approximately 510 million patients, on the other hand, had uncorrected near vision impairment. Most of these populations live in low-middle-income countries, accounting for 90% of cases. Around 895 million people will be suffering from distance vision impairment by 2050, and 61 million be blind. The increasing target population offers high growth opportunities to the players.

OPHTHALMOSCOPES MARKET TRENDS

Technological innovations and advanced products will further optimize the usage of ophthalmoscope devices in the industry. Scanning laser ophthalmoscopes have been available in the market since the 1990s, but recently increasing popularity and plenty of advantages delivery gives new direction to the industry. Currently, scanning laser ophthalmoscopes improved significantly. These ophthalmoscopes can obtain images with broader views of the ocular fundus with maintaining high resolution and increasing the application rate in eye examinations. These are superior in conventional fundoscopy with their ability to image abnormal alteration of choroid and retina. According to a recent report on the global medical laser market, the medical laser industry is growing at a CAGR of 13.9% from 2022 to 2027.

On the other side, indirect laser ophthalmoscopy, smartphone base indirect ophthalmoscope, and vision boost technology are some innovations that are revolutionizing the industry. Also, the rising application of ophthalmoscopes in other medical fields such as neurology and headache treatment will create new opportunities in the upcoming time.

VENDOR ANALYSIS

  • In 2021, Heine launched a new indirect ophthalmoscope with the product Omega600. By introducing new products, the company made a significant change in the market with vision boost technology to increase the illumination and increase the clinician's capability to test the patient's cataract condition and vitreous opacities.
  • In 2021, the BMJ journal reported that the smartphone ophthalmoscopy technology has a potential way in the covid-19 era for non-ophthalmology medicine. Smartphone ophthalmoscope has generally accounted for more favorably than direct handling time. This device gives the practitioners the capacity of long-distance working to examine and view the fundus from around arm's length compared to the general Ophthalmoscope.
  • In 2021, the Hillrom company introduced the Welch Allyn PanOptic Plus Ophthalmoscope devices that boast a 20X larger viewing area.

MARKET DRIVERS

Manufacturers' enhanced efforts to promote awareness about developments in ophthalmoscope technology are driving the global ophthalmoscopes market expansion. Furthermore, rising healthcare expenditures for the treatment of vision loss, blindness, and sight-threatening disorders are predicted to boost demand for primary eye care and examinations, hence, increasing the demand for critical equipment such as ophthalmoscopes over the forecast period. On the other side increasing prevalence of eye diseases influence the need for eye examination and drives the high growth of ophthalmoscopes applications. Cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration are the primary eye condition that requires ophthalmoscopes.

The increasing prevalence of the above conditions and excellent access to eye care services in developed countries positively triggered the application rate of ophthalmoscopes. Rising prevalence led to an eye examination and its demand for the ophthalmoscopy for diabetes retinopathy, cataract, glaucoma, corneal opacities, and other eye conditions.

The global ophthalmoscopes market was valued at USD 53.02 million in 2021 and is expected to reach USD 73.90 million by 2027, growing at a CAGR of 5.69%. As per the Arizton Analysis, based on eye disease prevalence, the introduction of advanced technology ophthalmoscopes, and rising awareness and eye examination rate are some factors propelling the industry growth. Based on analysis industry will reach USD 73.90 million by 2027. Vision impairment poses an enormous global burden; the yearly international costs of productivity losses related to vision impairment from untreated myopia and presbyopia alone are estimated to be USD 244 billion and USD 25.4 billion, respectively.

SEGMENTATION ANALYSIS

  • The Ophthalmoscopes market is segmented into direct & indirect ophthalmoscopes. Welch Allyn, Nidek Inc, Heine USA Ltd., US ophthalmic, Honsun Group, Iridex Corporation, Oscar Boscarlol S.r.l., Zumax Medical Co. Ltd, Rudolf Riester GmbH, Dino-Lite Europe, Medline Industries Inc. are some of the biggest direct ophthalmoscope manufacturing businesses.
  • In 2021, direct Ophthalmoscopes accounted for 60.16% of the industry share and stood in prime position.
  • Nidek Co. Inc, Ellex Medical Laser Ltd, Carls Zeiss, Ziemer Ophthalmic System Ag, Keeler Ltd, Heine Optotechnik GmbH, Topcon Medical Laser System, Iridex Corporation, Lumenis Ltd, and others are among the leading manufacturers of indirect ophthalmoscopes.
  • The wide presence of players with a broad range of product portfolios gives a dynamic nature to the industry. A high number of market players and their global distribution channels increased the market growth.
  • The indication market is segmented into glaucoma, diabetic retinopathy, retinal detachment, age-related macular degeneration, cataracts, macular pucker, corneal opacities, trachoetc ma, presbyopia, myopia, astigmatism, peripheral neovascularization, lattice degeneration, etc.) eye diseases. The glaucoma segment accounted for 31.81% market share in 2021 and dominated the other indications. Diabetic retinopathy accounted for 23.37% of market share, age-related macular degeneration segmented accounted for 18.03% market share, and retinal detachment accounted for 5.27% of industry share in 2021.
  • End-user is segmented into eye clinics and Hospitals, ophthalmologists & optometrists, and ambulatory surgical centers. The wise presence of eye clinics and hospitals drives the high application rate of ophthalmoscopes for eye testing. In 2021, the eye clinics and hospitals segment accounted for 52.34% market share and dominated the other end-user segment. On the other side, ophthalmologists, optometrist segments, and ambulatory surgical centers accounted for 32.80% and 14.86% industry share. Ambulatory surgical centers are the most widely accepted eye care service, which consistently influenced the industry's growth.

GEOGRAPHICAL ANALYSIS

  • Eye care services are widely available in North America. The high prevalence of eye conditions, greater access to an eye examination, and high awareness drive the high application rate of ophthalmoscope medical devices. Also, the presence of ophthalmoscope market players significantly improved the growth in North America, with a 38.82% share in 2021.
  • Europe region stands in the second position with 32.89% market share. In 2021, Europe accounted for around USD 17.44 million and was expected to reach USD 24.34 million by 2027, growing at a CAGR of 5.71% during the forecast period. The increasing frequency of diabetic retinopathy, glaucoma, and cataracts prompted a high rate of ophthalmoscope use in eye care services, which fueled the market growth.
  • APAC region is home to diabetes conditions that drive the Ophthalmoscope to identify diabetic retinopathy. On the other side, a dense population and an aging population positively drive market growth in the region, accounting for 20.23% market share.
  • Latin America is an emerging market with increasing eye care expenditure, a rising patient population, and growing demand for eye care services. In 2021, Latin America accounted for 5.04% market share 2021.
  • Middle East & Africa is one of the major regions with significant growth opportunities for market growth. A high number of glaucoma, diabetic retinopathy, and blindness patients population and increasing government initiatives are the most common factors triggering the market growth in the region. In 2021, Middle East & Africa accounted for a 3.01% market share in the global ophthalmoscope market.

Frequently Asked Questions

HOW BIG IS THE OPHTHALMOSCOPES MARKET?

The global ophthalmoscopes market was valued at USD 53.02 million in 2021 and is expected to reach USD 73.90 million by 2027, growing at a CAGR of 5.69%.

WHAT ARE THE LATEST TRENDS IN THE OPHTHALMOSCOPES MARKET?

Technological advancements and new applications of ophthalmoscopy are the latest market trends in the ophthalmoscopes market.

WHO ARE THE KEY PLAYERS IN THE OPHTHALMOSCOPES MARKET?

Key players include Heine USA Ltd, Dino-Lite Europe, Iridex Corporation, Nidek Co. Ltd., Oscar Boscarol S.r.l, Rudolf Riester GmbH, AND US Ophthalmic.

WHAT ARE THE GROWTH ENABLERS IN THE OPHTHALMOSCOPES MARKET?

Rising awareness among the patient population with increasing the eye care services in developed countries and eye disorders prevalence & surgical procedures are some of the growth enablers in the ophthalmoscopes market.

WHICH END-USER SEGMENT TO HOLD THE LARGEST SHARE IN THE OPHTHALMOSCOPE MARKET BY 2027?

Eye clinics & hospitals will hold the largest share in the ophthalmoscope end-user segment by 2027.

Download Free Sample

The global ophthalmoscopes market was valued at USD 53.02 million in 2021 and is expected to reach USD 73.90 million by 2027.

The following factors are likely to contribute to the global ophthalmoscope market growth during the forecast period:

  • Raising Awareness Among Patients Population by Increasing the Eye Care Services in Developed Countries
  • Increasing Eye Disorders Prevalence & Surgical Procedures
  • Surging Prevalence of Eye Disorders Patient Population
  • Increasing Government Initiative for Eye Care

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the ophthalmoscope market and its market dynamics for 2022−2027. It covers a detailed overview of several industry growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

Key Players

  • Heine USA Ltd
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Dino Lite Europe
  • Iridex Corporation
  • Halma
  • Nidek Co. Ltd.
  • Oscar Boscarol S.r.l
  • Rudolf Riester GmbH
  • US Ophthalmic

Other Prominent Vendors

  • Albert Waeschle
    • Business Overview
    • Product Offerings
  • American Diagnostic Corporation
  • Shanghai Bolan Optical Electric Co Ltd
  • Carl Zeiss
  • Ellex
  • Essilor International (Essilor Instruments USA)
  • Heidelberg Engineering
  • Invotech Excel
  • Medline Industries LP
  • Neitz Instruments Co Ltd
  • Suzhou Kangjie Medical Inc
  • Spengler
  • Topcon Co. Ltd
  • Lumenis
  • Zumax Medical
  • 66 Vision Tech
  • Zhejiang Honsun Medical Technologies Co. Ltd

Segmentation by Type

  • Direct
  • Indirect

Segmentation by Indication

  • Glaucoma
  • Diabetic Retinopathy
  • Age-Related Macular Degeneration
  • Retinal Detachment
  • Other

Segmentation by End-User

  • Eye Clinics & Hospitals
  • Ophthalmologist & Optometrist
  • Ambulatory Surgical Centres

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY TYPE

4.3.2 MARKET SEGMENTATION BY INDICATION

4.3.3 MARKET SEGMENTATION BY END-USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 TECHNOLOGICAL ADVANCES & NEW APPLICATIONS OF OPHTHALMOSCOPES

8.2 GOVERNMENT’S EYE CARE INITIATIVES

8.3 HIGHER GROWTH OPPORTUNITIES IN EMERGING MARKETS

9 MARKET GROWTH ENABLERS

9.1 RISE IN AWARENESS OF EYE CARE SERVICES IN DEVELOPED COUNTRIES

9.2 RISE IN EYE DISORDER PREVALENCE & SURGICAL PROCEDURES

9.3 ADVENT OF ADVANCED OPHTHALMOSCOPES

9.4 INCREASE IN PATIENT POPULATION WITH EYE DISORDERS

10 MARKET RESTRAINTS

10.1 LACK OF EYE CARE SERVICES IN EMERGING MARKETS

10.2 INSUFFICIENT OPHTHALMOLOGISTS IN DEVELOPING COUNTRIES

10.3 STRINGENT REGULATIONS & PRODUCT RECALLS

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 INSIGHTS BY GEOGRAPHY

11.2.2 INSIGHTS BY TYPE

11.2.3 INSIGHTS BY INDICATION

11.2.4 INSIGHTS BY END-USER

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 TYPE

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 DIRECT OPHTHALMOSCOPE

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 MARKET BY GEOGRAPHY

12.4 INDIRECT OPHTHALMOSCOPE

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 MARKET BY GEOGRAPHY

13 INDICATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 GLAUCOMA

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 DIABETIC RETINOPATHY

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 AGE-RELATED MACULAR DEGENERATION

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

13.6 RETINAL DETACHMENT

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 MARKET BY GEOGRAPHY

13.7 OTHERS

13.7.1 MARKET OVERVIEW

13.7.2 MARKET SIZE & FORECAST

13.7.3 MARKET BY GEOGRAPHY

14 END-USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 EYE CLINICS & HOSPITALS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 OPHTHALMOLOGISTS AND OPTOMETRISTS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 AMBULATORY SURGICAL CENTERS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.3 TYPE

16.3.1 MARKET SIZE & FORECAST

16.4 INDICATION

16.4.1 MARKET SIZE & FORECAST

16.5 END-USER

16.5.1 MARKET SIZE & FORECAST

16.6 KEY COUNTRIES

16.6.1 US: MARKET SIZE & FORECAST

16.6.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 TYPE

17.3.1 MARKET SIZE & FORECAST

17.4 INDICATION

17.4.1 MARKET SIZE & FORECAST

17.5 END-USER

17.5.1 MARKET SIZE & FORECAST

17.6 KEY COUNTRIES

17.6.1 GERMANY: MARKET SIZE & FORECAST

17.6.2 FRANCE: MARKET SIZE & FORECAST

17.6.3 UK: MARKET SIZE & FORECAST

17.6.4 ITALY: MARKET SIZE & FORECAST

17.6.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 TYPE

18.3.1 MARKET SIZE & FORECAST

18.4 INDICATION

18.4.1 MARKET SIZE & FORECAST

18.5 END-USER

18.5.1 MARKET SIZE & FORECAST

18.6 KEY COUNTRIES

18.6.1 JAPAN: MARKET SIZE & FORECAST

18.6.2 CHINA: MARKET SIZE & FORECAST

18.6.3 INDIA: MARKET SIZE & FORECAST

18.6.4 AUSTRALIA: MARKET SIZE & FORECAST

18.6.5 SOUTH KOREA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 TYPE

19.3.1 MARKET SIZE & FORECAST

19.4 INDICATION

19.4.1 MARKET SIZE & FORECAST

19.5 END-USER

19.5.1 MARKET SIZE & FORECAST

19.6 KEY COUNTRIES

19.6.1 BRAZIL: MARKET SIZE & FORECAST

19.6.2 MEXICO: MARKET SIZE & FORECAST

19.6.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 TYPE

20.3.1 MARKET SIZE & FORECAST

20.4 INDICATION

20.4.1 MARKET SIZE & FORECAST

20.5 END-USER

20.5.1 MARKET SIZE & FORECAST

20.6 KEY COUNTRIES

20.6.1 TURKEY: MARKET SIZE & FORECAST

20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST

20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

22 KEY COMPANY PROFILES

22.1 HEINE

22.1.1 BUSINESS OVERVIEW

22.1.2 PRODUCT OFFERINGS

22.1.3 KEY STRATEGIES

22.1.4 KEY STRENGTHS

22.1.5 KEY OPPORTUNITIES

22.2 DINO-LITE EUROPE (ANMO ELECTRONICS CORPORATION)

22.2.1 BUSINESS OVERVIEW

22.2.2 PRODUCT OFFERINGS

22.2.3 KEY STRATEGIES

22.2.4 KEY STRENGTHS

22.2.5 KEY OPPORTUNITIES

22.3 IRIDEX

22.3.1 BUSINESS OVERVIEW

22.3.2 PRODUCT OFFERINGS

22.3.3 KEY STRATEGIES

22.3.4 KEY STRENGTHS

22.3.5 KEY OPPORTUNITIES

22.4 HALMA

22.4.1 BUSINESS OVERVIEW

22.4.2 PRODUCT OFFERINGS

22.4.3 KEY STRATEGIES

22.4.4 KEY STRENGTHS

22.4.5 KEY OPPORTUNITIES

22.5 NIDEK

22.5.1 BUSINESS OVERVIEW

22.5.2 PRODUCT OFFERINGS

22.5.3 KEY STRATEGIES

22.5.4 KEY STRENGTHS

22.5.5 KEY OPPORTUNITY

22.6 OSCAR BOSCAROL

22.6.1 BUSINESS OVERVIEW

22.6.2 PRODUCT OFFERINGS

22.6.3 KEY STRATEGIES

22.6.4 KEY STRATEGIES

22.6.5 KEY OPPORTUNITIES

22.7 RUDOLF RIESTER

22.7.1 BUSINESS OVERVIEW

22.7.2 PRODUCT OFFERINGS

22.7.3 KEY STRATEGIES

22.7.4 KEY STRENGTHS

22.7.5 KEY OPPORTUNITIES

22.8 WELCH ALLYN (HILL ROM)

22.8.1 BUSINESS OVERVIEW

22.8.2 PRODUCT OFFERINGS

22.8.3 KEY STRATEGIES

22.8.4 KEY STRENGTHS

22.8.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

23.1 ALBERT WAESCHLE

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.2 AMERICAN DIAGNOSTIC CORPORATION

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.3 SHANGHAI BOLAN OPTICAL ELECTRIC

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.4 CARL ZEISS

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.5 LUMIBIRD GROUP (ELLEX)

23.5.1 BUSINESS OVERVIEW

23.5.2 PRODUCT OFFERING

23.6 ESSILOR INTERNATIONAL (ESSILOR INSTRUMENTS USA)

23.6.1 BUSINESS OVERVIEW

23.6.2 PRODUCT OFFERING

23.7 HEIDELBERG ENGINEERING

23.7.1 BUSINESS OVERVIEW

23.7.2 PRODUCT OFFERINGS

23.8 INVOTECH EXCEL

23.8.1 BUSINESS OVERVIEW

23.8.2 PRODUCT OFFERINGS

23.9 MEDLINE INDUSTRIES

23.9.1 BUSINESS OVERVIEW

23.9.2 PRODUCT OFFERINGS

23.10 NEITZ INSTRUMENTS

23.10.1 BUSINESS OVERVIEW

23.10.2 PRODUCT OFFERINGS

23.11 SUZHOU KANGJIE MEDICAL

23.11.1 BUSINESS OVERVIEW

23.11.2 PRODUCT OFFERINGS

23.12 SPENGLER HOLTEX GROUP

23.12.1 BUSINESS OVERVIEW

23.12.2 PRODUCT OFFERINGS

23.13 TOPCON

23.13.1 BUSINESS OVERVIEW

23.13.2 PRODUCT OFFERINGS

23.14 LUMENIS

23.14.1 BUSINESS OVERVIEW

23.14.2 PRODUCT OFFERINGS

23.15 ZUMAX MEDICAL CO. LTD

23.15.1 BUSINESS OVERVIEW

23.15.2 PRODUCT OFFERINGS

23.16 66 VISION TECH

23.16.1 BUSINESS OVERVIEW

23.16.2 PRODUCT OFFERINGS

23.17 ZHEJIANG HONSUN MEDICAL TECHNOLOGIES CO. LTD

23.17.1 BUSINESS OVERVIEW

23.17.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS

24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

25.1 GEOGRAPHY

25.2 TYPE

25.3 INDICATION

25.4 END-USER

25.5 TYPE (GEOGRAPHICAL DISTRIBUTION)

25.5.1 DIRECT OPHTHALMOSCOPE: MARKET BY GEOGRAPHY

25.5.2 INDIRECT OPHTHALMOSCOPE: MARKET BY GEOGRAPHY

25.6 INDICATION (GEOGRAPHICAL DISTRIBUTION)

25.6.1 GLAUCOMA: MARKET BY GEOGRAPHY

25.6.2 DIABETIC RETINOPATHY: MARKET BY GEOGRAPHY

25.6.3 AGE-RELATED MACULAR DEGENERATION: MARKET BY GEOGRAPHY

25.6.4 RETINAL DETACHMENT: MARKET BY GEOGRAPHY

25.6.5 OTHERS: MARKET BY GEOGRAPHY

25.7 END-USER (GEOGRAPHICAL DISTRIBUTION)

25.7.1 EYE CLINICS & HOSPITALS: MARKET BY GEOGRAPHY

25.7.2 OPHTHALMOLOGISTS & OPTOMETRISTS: MARKET BY GEOGRAPHY

25.7.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY

26 APPENDIX

26.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 GLOBAL OPHTHALMOSCOPE MARKET: SEGMENTATION

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 GLOBAL EYE HEALTH 2020

EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCES & NEW APPLICATIONS OF OPHTHALMOSCOPES

EXHIBIT 5 TECHNOLOGICAL ADVANCES IN OPHTHALMOSCOPES

EXHIBIT 6 IMPACT OF GOVERNMENT’S EYE CARE INITIATIVES

EXHIBIT 7 IMPACT OF HIGHER GROWTH OPPORTUNITIES IN EMERGING MARKETS

EXHIBIT 8 EMERGING MARKETS & HEALTHCARE & EYE CARE DEVELOPMENT WITH EXPENDITURE (2019)

EXHIBIT 9 IMPACT OF RISE IN AWARENESS OF EYE CARE SERVICES IN DEVELOPED COUNTRIES

EXHIBIT 10 IMPACT OF RISE IN EYE DISORDER PREVALENCE & SURGICAL PROCEDURES

EXHIBIT 11 MAJOR EYE DISEASES THAT REQUIRE OPHTHALMOSCOPES FOR EXAMINATIONS

EXHIBIT 12 DIABETIC RETINOPATHY PREVALENCE BY REGION 2021

EXHIBIT 13 IMPACT OF ADVENT OF ADVANCED OPHTHALMOSCOPES

EXHIBIT 14 IMPACT OF INCREASE IN PATIENT POPULATION WITH EYE DISORDERS

EXHIBIT 15 GLOBAL KEY FACTS ABOUT BLINDNESS & VISION IMPAIRMENT

EXHIBIT 16 EYE DISORDERS WITH AN ESTIMATED PREVALENCE

EXHIBIT 17 IMPACT OF LACK OF EYE CARE SERVICES IN EMERGING MARKETS

EXHIBIT 18 IMPACT OF INSUFFICIENT OPHTHALMOLOGISTS IN DEVELOPING COUNTRIES

EXHIBIT 19 OPHTHALMOLOGISTS IN LOWER-MIDDLE-INCOME COUNTRIES

EXHIBIT 20 IMPACT OF STRINGENT REGULATIONS & PRODUCT RECALLS

EXHIBIT 21 GLOBAL OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 22 GLOBAL OPHTHALMOSCOPE MARKET SHARE BY GEOGRAPHY 2021–2027 (%)

EXHIBIT 23 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2021–2027 (% SHARE)

EXHIBIT 24 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2021–2027 (% SHARE)

EXHIBIT 25 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2021–2027 (% SHARE)

EXHIBIT 26 FIVE FORCES ANALYSIS 2021

EXHIBIT 27 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 28 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2022–2027

EXHIBIT 29 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE: INCREMENTAL GROWTH

EXHIBIT 30 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE: ABSOLUTE GROWTH

EXHIBIT 31 RETINAL DISEASES THAT REQUIRE OPHTHALMOSCOPES & EYE EXAMINATIONS

EXHIBIT 32 GLOBAL OPHTHALMOSCOPE MARKET BY DIRECT OPHTHALMOSCOPE: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 33 GLOBAL OPHTHALMOSCOPE MARKET BY DIRECT OPHTHALMOSCOPE 2021–2027 ($ MILLION)

EXHIBIT 34 LATTICE DEGENERATION PREVALENCE WITH EYE CONDITIONS 2021

EXHIBIT 35 GLOBAL OPHTHALMOSCOPE MARKET BY INDIRECT OPHTHALMOSCOPE: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 36 GLOBAL OPHTHALMOSCOPE MARKET BY INDIRECT OPHTHALMOSCOPE 2021–2027 ($ MILLION)

EXHIBIT 37 INCREMENTAL GROWTH BY SEGMENT 2021 & 2027

EXHIBIT 38 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2022–2027

EXHIBIT 39 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION: INCREMENTAL GROWTH

EXHIBIT 40 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION: ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL GLAUCOMA PREVALENCE BY WHO

EXHIBIT 42 GLOBAL PREVALENCE OF PROGRESSIVE OPEN-ANGLE GLAUCOMA 2021

EXHIBIT 43 GLOBAL PROJECTED GLAUCOMA PREVALENCE BY 2040 (MILLION)

EXHIBIT 44 GLOBAL OPHTHALMOSCOPE MARKET BY GLAUCOMA: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 45 GLOBAL OPHTHALMOSCOPE MARKET BY GLAUCOMA 2021–2027 ($ MILLION)

EXHIBIT 46 GLOBAL DIABETIC RETINOPATHY PREVALENCE 2021 (MILLION)

EXHIBIT 47 DIABETIC RETINOPATHY PREVALENCE BY REGION 2021

EXHIBIT 48 GLOBAL OPHTHALMOSCOPE MARKET BY DIABETIC RETINOPATHY: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL OPHTHALMOSCOPE MARKET BY DIABETIC RETINOPATHY 2021–2027 ($ MILLION)

EXHIBIT 50 GLOBAL OPHTHALMOSCOPE MARKET BY AGE-RELATED MACULAR DEGENERATION 2021–2027 ($ MILLION)

EXHIBIT 51 GLOBAL OPHTHALMOSCOPE MARKET BY AGE-RELATED MACULAR DEGENERATION: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL OPHTHALMOSCOPE MARKET BY RETINAL DETACHMENT: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 53 GLOBAL OPHTHALMOSCOPE MARKET BY RETINAL DETACHMENT 2021–2027 ($ MILLION)

EXHIBIT 54 OTHER EYE DISEASES DIAGNOSED USING OPHTHALMOSCOPES

EXHIBIT 55 GLOBAL OPHTHALMOSCOPE MARKET BY OTHERS: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 56 GLOBAL OPHTHALMOSCOPE MARKET BY OTHERS 2021–2027 ($ MILLION)

EXHIBIT 57 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 58 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2022–2027

EXHIBIT 59 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 60 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 61 GLOBAL OPHTHALMOSCOPE MARKET BY EYE CLINICS & HOSPITALS: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL OPHTHALMOSCOPE MARKET BY EYE CLINICS & HOSPITALS 2021–2027 ($ MILLION)

EXHIBIT 63 TOTAL NUMBER OF GLOBAL OPHTHALMOLOGISTS IN 2015

EXHIBIT 64 GLOBAL OPHTHALMOSCOPE MARKET BY OPHTHALMOLOGISTS & OPTOMETRISTS: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 65 GLOBAL OPHTHALMOSCOPE MARKET BY OPHTHALMOLOGISTS & OPTOMETRISTS 2021–2027 ($ MILLION)

EXHIBIT 66 REASON FOR HIGH DEMAND FOR ACSS IN THE EYE CARE SECTOR

EXHIBIT 67 GLOBAL OPHTHALMOSCOPE MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 68 GLOBAL OPHTHALMOSCOPE MARKET BY AMBULATORY SURGICAL CENTERS 2021–2027 ($ MILLION)

EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 70 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2022–2027

EXHIBIT 71 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 72 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY INCREMENTAL GROWTH

EXHIBIT 73 NORTH AMERICA OPHTHALMOSCOPE MARKET: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 74 NORTH AMERICA OPHTHALMOSCOPE MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 75 OPHTHALMOSCOPE MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)

EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 77 EYE DISORDERS PREVALENCE IN US 2015–2020

EXHIBIT 78 EYE DISEASE PREVALENCE IN THE US

EXHIBIT 79 US OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 80 CANADA: EYE CONDITIONS AND PREVALENCE RATE

EXHIBIT 81 CANADA OPHTHALMOSCOPE MARKET 2022–2027 ($ MILLION)

EXHIBIT 82 EUROPE: PREVALENCE OF EYE DISEASES

EXHIBIT 83 OPHTHALMOSCOPE MARKET EUROPE: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 84 EUROPE OPHTHALMOSCOPE MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 85 OPHTHALMOSCOPE MARKET IN EUROPE 2021–2027 ($ MILLION)

EXHIBIT 86 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 87 GERMANY OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 88 FRANCE OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 89 PRIMARY OPEN-ANGLE GLAUCOMA PREVALENCE IN THE UK BY AGE (40 YEARS, 60 YEARS, AND 80 YEARS)

EXHIBIT 90 UK OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 91 ITALY: EYE DISEASE PREVALENCE IN PEOPLE AGED 50 YEARS AND OVER

EXHIBIT 92 ITALY OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 93 NORTHERN SPAIN: DIABETIC RETINOPATHY PREVALENCE 2020

EXHIBIT 94 SPAIN OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 95 APAC EYE DISEASE PREVALENCE

EXHIBIT 96 POPULATION WITH MODERATE-TO-SEVERE VISUAL IMPAIRMENT IN APAC 2019 (MILLION)

EXHIBIT 97 OPHTHALMOSCOPE MARKET APAC: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 98 APAC OPHTHALMOSCOPE MARKET: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 99 OPHTHALMOSCOPE MARKET IN APAC 2021–2027 ($ MILLION)

EXHIBIT 100 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 101 VISUAL IMPAIRMENT CAUSING DISEASES 2021 (% SHARE)

EXHIBIT 102 JAPAN OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 103 CHINA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 104 INDIA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 105 AUSTRALIA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 106 SOUTH KOREA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 107 OPHTHALMOSCOPE MARKET IN LATIN AMERICA: INCREMENTAL GROWTH &ABSOLUTE GROWTH

EXHIBIT 108 OPHTHALMOSCOPE MARKET IN LATIN AMERICA: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 109 OPHTHALMOSCOPE MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)

EXHIBIT 110 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 111 BRAZIL OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 112 MEXICO OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 113 PREVALENCE OF EYE DISEASES & RELATIVE PERCENTAGE OF FIVE PRINCIPAL DIAGNOSIS 2014–2017

EXHIBIT 114 ARGENTINA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 115 OPHTHALMOSCOPE MARKET IN THE MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 116 OPHTHALMOSCOPE MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES 2021 ($ MILLION)

EXHIBIT 117 OPHTHALMOSCOPE MARKET IN THE MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

EXHIBIT 118 INCREMENTAL GROWTH IN THE MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 119 CRUDE PREVALENCE OF VISION LOSS IN TURKEY IN 2020 (%)

EXHIBIT 120 TURKEY: ADULT POPULATION WITH EYE DISEASES (%)

EXHIBIT 121 TURKEY OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 122 SOUTH AFRICA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 123 PREVALENCE OF VISUAL IMPAIRMENT-CAUSING DISEASES 2020

EXHIBIT 124 SAUDI ARABIA OPHTHALMOSCOPE MARKET 2021–2027 ($ MILLION)

EXHIBIT 125 IRIDEX ANNUAL REVENUE 2017–2020 ($ MILLION)

EXHIBIT 126 HALMA ANNUAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 127 NIDEK: ANNUAL REPORT 2018–2020 ($ MILLION)

EXHIBIT 128 NIDEK: BUSINESS SEGMENT ANNUAL REVENUE 2020 ($ MILLION)

EXHIBIT 129 NIDEK: ANNUAL REVENUE BY GEOGRAPHY 2020 (% SHARE)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 4 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 5 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 6 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (% SHARE)

TABLE 7 GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 8 GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 9 DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 10 DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 11 AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 12 AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 13 RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 14 RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 15 OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 16 OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 17 EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 18 EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 19 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 20 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 21 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 22 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 23 OPHTHALMOSCOPE MARKET BY TYPE IN NORTH AMERICA 2021–2027 ($ MILLION)

TABLE 24 OPHTHALMOSCOPE MARKET BY TYPE IN NORTH AMERICA 2021–2027 (%)

TABLE 25 OPHTHALMOSCOPE MARKET BY INDICATION IN NORTH AMERICA 2021–2027 ($ MILLION)

TABLE 26 OPHTHALMOSCOPE MARKET BY INDICATION IN NORTH AMERICA 2021–2027 (%)

TABLE 27 OPHTHALMOSCOPE MARKET BY END-USER IN NORTH AMERICA 2021–2027 ($ MILLION)

TABLE 28 OPHTHALMOSCOPE MARKET BY END-USER IN NORTH AMERICA 2021–2027 (%)

TABLE 29 OPHTHALMOSCOPE MARKET BY TYPE IN EUROPE 2021–2027 ($ MILLION)

TABLE 30 OPHTHALMOSCOPE MARKET BY TYPE IN EUROPE 2021–2027 (%)

TABLE 31 OPHTHALMOSCOPE MARKET BY INDICATION IN EUROPE 2021–2027 ($ MILLION)

TABLE 32 OPHTHALMOSCOPE MARKET BY INDICATION IN EUROPE 2021–2027 (%)

TABLE 33 OPHTHALMOSCOPE MARKET BY END-USER IN EUROPE 2021–2027 ($ MILLION)

TABLE 34 OPHTHALMOSCOPE MARKET BY END-USER IN EUROPE 2021–2027 (%)

TABLE 35 OPHTHALMOSCOPE MARKET BY TYPE IN APAC 2021–2027 ($ MILLION)

TABLE 36 OPHTHALMOSCOPE MARKET BY TYPE IN APAC 2021–2027 (%)

TABLE 37 OPHTHALMOSCOPE MARKET BY INDICATION IN APAC 2021–2027 ($ MILLION)

TABLE 38 OPHTHALMOSCOPE MARKET BY INDICATION IN APAC 2021–2027 (%)

TABLE 39 OPHTHALMOSCOPE MARKET BY END-USER IN APAC 2021–2027 ($ MILLION)

TABLE 40 OPHTHALMOSCOPE MARKET BY END-USER IN APAC 2021–2027 (%)

TABLE 41 OPHTHALMOSCOPE MARKET BY TYPE IN LATIN AMERICA 2021–2027 ($ MILLION)

TABLE 42 OPHTHALMOSCOPE MARKET BY TYPE IN LATIN AMERICA 2021–2027 (%)

TABLE 43 OPHTHALMOSCOPE MARKET BY INDICATION IN LATIN AMERICA 2021–2027 ($ MILLION)

TABLE 44 OPHTHALMOSCOPE MARKET BY INDICATION IN LATIN AMERICA 2021–2027 (%)

TABLE 45 OPHTHALMOSCOPE MARKET BY END-USER IN LATIN AMERICA 2021–2027 ($ MILLION)

TABLE 46 OPHTHALMOSCOPE MARKET BY END-USER IN LATIN AMERICA 2021–2027 (%)

TABLE 47 OPHTHALMOSCOPE MARKET BY TYPE IN THE MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

TABLE 48 OPHTHALMOSCOPE MARKET BY TYPE IN THE MIDDLE EAST & AFRICA 2021–2027 (%)

TABLE 49 OPHTHALMOSCOPE MARKET BY INDICATION IN THE MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

TABLE 50 OPHTHALMOSCOPE MARKET BY INDICATION IN THE MIDDLE EAST & AFRICA 2021–2027 (%)

TABLE 51 OPHTHALMOSCOPE MARKET BY END-USER IN THE MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

TABLE 52 OPHTHALMOSCOPE MARKET BY END-USER IN THE MIDDLE EAST & AFRICA 2021–2027 (%)

TABLE 53 HEINE OPTOTECHNIK: MAJOR PRODUCT OFFERINGS

TABLE 54 DINO-LITE EUROPE: MAJOR PRODUCT OFFERINGS

TABLE 55 IRIDEX: MAJOR PRODUCT OFFERINGS

TABLE 56 HALMA: MAJOR PRODUCT OFFERINGS

TABLE 57 NIDEK: MAJOR PRODUCT OFFERINGS

TABLE 58 OSCAR BOSCAROL: MAJOR PRODUCT OFFERINGS

TABLE 59 RUDOLF RIESTER: MAJOR PRODUCT OFFERINGS

TABLE 60 WELCH ALLYN: MAJOR PRODUCT OFFERINGS

TABLE 61 ALBERT WAESCHLE: MAJOR PRODUCT OFFERINGS

TABLE 62 AMERICAN DIAGNOSTIC CORPORATION: MAJOR PRODUCT OFFERINGS

TABLE 63 SHANGHAI BOLAN OPTICAL ELECTRIC: MAJOR PRODUCT OFFERINGS

TABLE 64 CARL ZEISS: MAJOR PRODUCT OFFERINGS

TABLE 65 ELLEX: MAJOR PRODUCT OFFERINGS

TABLE 66 ESSILOR INTERNATIONAL (ESSILOR INSTRUMENTS USA): MAJOR PRODUCT OFFERINGS

TABLE 67 HEIDELBERG ENGINEERING: MAJOR PRODUCT OFFERINGS

TABLE 68 INVOTECH EXCEL: MAJOR PRODUCT OFFERINGS

TABLE 69 MEDLINE INDUSTRIES: MAJOR PRODUCT OFFERINGS

TABLE 70 NEITZ INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 71 SUZHOU KANGJIE MEDICAL INC: MAJOR PRODUCT OFFERINGS

TABLE 72 SPENGLER HOLTEX GROUP: MAJOR PRODUCT OFFERINGS

TABLE 73 TOPCON: MAJOR PRODUCT OFFERINGS

TABLE 74 LUMENIS: MAJOR PRODUCT OFFERINGS

TABLE 75 ZUMAX MEDICAL CO. LTD.: MAJOR PRODUCT OFFERINGS

TABLE 76 66 VISION TECH: MAJOR PRODUCT OFFERINGS

TABLE 77 ZHEJIANG HONSUN MEDICAL TECHNOLOGIES CO. LTD: MAJOR PRODUCT OFFERINGS

TABLE 78 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 79 GLOBAL OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 80 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2021–2027 ($ MILLION)

TABLE 81 GLOBAL OPHTHALMOSCOPE MARKET BY TYPE 2021–2027 (%)

TABLE 82 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2021–2027 ($ MILLION)

TABLE 83 GLOBAL OPHTHALMOSCOPE MARKET BY INDICATION 2021–2027 (%)

TABLE 84 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 85 GLOBAL OPHTHALMOSCOPE MARKET BY END-USER 2021–2027 (%)

TABLE 86 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 87 GLOBAL DIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 88 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 89 GLOBAL INDIRECT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 90 GLOBAL GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 91 GLOBAL GLAUCOMA OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 92 GLOBAL DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 93 GLOBAL DIABETIC RETINOPATHY OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 94 GLOBAL AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 95 GLOBAL AGE-RELATED MACULAR DEGENERATION OPHTHALMOSCOPE BY GEOGRAPHY 2021–2027 (%)

TABLE 96 GLOBAL RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 97 GLOBAL RETINAL DETACHMENT OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 98 GLOBAL OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 99 GLOBAL OTHERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 100 GLOBAL EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 101 GLOBAL EYE CLINICS & HOSPITALS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 102 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 103 GLOBAL OPHTHALMOLOGISTS & OPTOMETRISTS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 104 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 105 GLOBAL AMBULATORY SURGICAL CENTERS OPHTHALMOSCOPE MARKET BY GEOGRAPHY 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date